FEB 16, 2016 01:31 PM PST

Noradrenergic Signaling Determines Resilience to Depression

WRITTEN BY: Cassidy Reich
Resilience and susceptibility to depression are a complex mix of many factors. Understanding why some individuals are resilient could lead to new pathways and systems to target for the treatment, or even prevention, of depression. Researchers led by Bruno Giros at McGill University have identified a specific circuit that confers resilience to social defeat-induced depression.

Dopamine neurons in the ventral tegmental area (VTA) have long been know to play a role in stress resilience. The VTA is a crucial part of the limbic system, colloquially known as the reward pathway, a circuit that is heavily implicated in mood disorders and addiction. Previous work has shown that the dopamine (DA) neurons in the VTA are more excitable in the brains of mice that are susceptible to depression.The research presented in this recent Nature Neuroscience paper details the noradrenergic control of the DA neurons in the VTA as a crucial factor in determining resilience to social defeat-induced depression.

After 10 days of chronic social defeat stress, mice were determined to be either resilient or susceptible to social defeat-induced depression by measure of social aversion. The mice categorized as susceptible had less noradrenergic tissue in the VTA compared to the resilient mice, or wild type mice not exposed to social defeat stress. (Note: noradrenaline = norepinephrine, abbreviation is NE). The NE neurons originate in a region called the locus coeruleus (LC) and project to the VTA. The susceptible mice had less NE being released in the VTA and had more DA neuron excitability while the resilient mice had more NE and less DA activity. Specifically, the DA neurons in the VTA that exhibited more bursting activity in the susceptible mice were projecting to the nucleus accumbens (NAc), not the medial prefrontal cortex (mPFC). Both the NAc and mPFC are part of the limbic system. From this, the researchers concluded that resilience to depression is determined by the level of NE-mediated inhibition of DA activity in the VTA.
  

To confirm this further, they tested this idea pharmacologically using an α2 noradrenergic receptor antagonist which has been shown to increase activity in the LC and increase NE release. Interestingly, chronic treatment with this antagonist reversed the susceptible phenotype in the mice, but acute treatment did not. The researchers also tried a selective NE reuptake inhibitor, similar in action to an SSRI, and again observed that chronic treatment made susceptible mice resilient, but acute treatment had no effect. A well-known issue with SSRIs is that they take weeks to exert their antidepressant effects, and it appears that the effects of increasing NE release in the VTA undergo a similar latency.

The main conclusion of the paper is that NE neurotransmission from the LC to the VTA is necessary and sufficient to confer resilience to stress-induced depression. The sheer amount of experiments and techniques used in this paper, many of which have not been summarized here, makes this finding very convincing. Hopefully, this paper will lead to increased research on and production of NE-focused antidepressant treatments, and also investigations into why the NE reuptake inhibitors and SSRIs have such a long lag time between drug treatment initiation and antidepressant effects.
About the Author
  • Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Mighty Multitasker, Mitochondria Do More Than Power The Cell
We all remember the mighty mitochondria from high school biology. These cellular power-houses are best known for their role in energy production. Specifica...
SEP 15, 2019
Cell & Molecular Biology
SEP 15, 2019
Exosomes are Involved in Brain Development
Researchers have learned more about the role of exosomes in neurodevelopment....
SEP 15, 2019
Technology
SEP 15, 2019
Novel Neural-Network Can Determine What Emotion An Image Evokes
Ever wondered if a computer may someday differentiate between joyful images from a depressing one? Can it someday tell if a film is a romantic comedy or a...
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Ketamine is not an opioid, and treats depression in a novel way
In March, the U.S. Food and Drug Administration approved ketamine nasal spray to treat depression. Ketamine has gotten a bad rep as an opioid - which it is...
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Why Drugs that Work on Mice Don't Work on Humans
Mice are used as the frontline for drug testing for brain disorders. Why? Their brains are supposed to have much of the same functioning as ours. Moreover,...
SEP 15, 2019
Health & Medicine
SEP 15, 2019
Mutant sheep bred to help scientists understand rare child brain disease
Scientists at Edinburgh University’s Roslin Institute have created a flock of sheep that carry the gene for a heritable brain disorder in humans call...
Loading Comments...